INTS (Intensity Therapeutics) Institutional Ownership: 6.23% (As of Jul. 13, 2026)


INTS Intensity Therapeutics Inc INTS
28 GF Score
Price $4.78
! 1 Warning Sign
View Full Analysis

What is Intensity Therapeutics Institutional Ownership?

Intensity Therapeutics INTS -2.05% 28 Institutional Ownership is 6.23% as of Jul. 13, 2026. GuruFocus rates INTS with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intensity Therapeutics's institutional ownership is 6.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intensity Therapeutics's Insider Ownership is 4.73%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intensity Therapeutics's Float Percentage Of Total Shares Outstanding is 95.54%.

Intensity Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Intensity Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intensity Therapeutics Institutional Ownership Chart

Intensity Therapeutics Historical Data

The historical data trend for Intensity Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-06-30
Institutional Ownership 0.69 1.91 1.91 2.70 0.91 0.92 0.92 1.30 1.30 1.18
INTS
28GF Score
Intensity Therapeutics Inc INTS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intensity Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 6.23% mean?
Intensity Therapeutics (INTS) has a Institutional Ownership of 6.23% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Intensity Therapeutics and its competitors.
Is Intensity Therapeutics' Institutional Ownership too high?
Intensity Therapeutics' current Institutional Ownership is 6.23%. Overall, Intensity Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Intensity Therapeutics' Institutional Ownership compare to KPRX and PHIO?
Intensity Therapeutics' Institutional Ownership of 6.23% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Intensity Therapeutics and its competitors. Intensity Therapeutics's current Institutional Ownership is 6.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intensity Therapeutics stock overvalued right now?
Intensity Therapeutics (INTS) has a current Institutional Ownership of 6.23%. The current Institutional Ownership is 6.23%. Intensity Therapeutics' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Intensity Therapeutics (INTS), the current Institutional Ownership is 6.23% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intensity Therapeutics Business Description

Address 1 Enterprise Drive, Suite 430, Shelton, CT, USA, 06484-4779
Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
28GF Score

Get the complete analysis for INTS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.78
Price